Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: A North Central Cancer Treatment Group phase II trial
Steven R. Alberts, Mark Schroeder, Charles Erlichman, Preston D. Steen, Nathan R. Foster, Dennis F. Moore, Kendrith M. Rowland, Suresh Nair, Loren K. Tschetter, Tom R. Fitch
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: A North Central Cancer Treatment Group phase II trial'. Together they form a unique fingerprint.